Pulmonary Hypertension in Aortic Stenosis and Mitral Regurgitation: Rest and Exercise Echocardiography Significance.

Abstract:

:Valvular heart disease is a common cause of increased mean pulmonary artery pressure (PAP). Aortic stenosis and mitral regurgitation are frequently accompanied by pulmonary hypertension (PH), especially when they are severe and symptomatic. In asymptomatic patients, PH is rare, though the exact prevalence is unknown and mainly stems from the severity of the valvular heart disease and the presence of diastolic dysfunction. Exercise echocardiography has recently gained interest in depicting PH. In these asymptomatic patients, exercise PH is observed in about >40%. Either PH at rest (systolic PAP >50 mmHg) or during exercise (systolic PAP >60 mmHg) is a powerful determinant of outcome and is independently associated with reduced survival, regardless of the severity of the underlying valvular pathology.

journal_name

Prog Cardiovasc Dis

authors

Martinez C,Bernard A,Dulgheru R,Incarnato P,Oury C,Lancellotti P

doi

10.1016/j.pcad.2016.06.004

subject

Has Abstract

pub_date

2016-07-01 00:00:00

pages

59-70

issue

1

eissn

0033-0620

issn

1873-1740

pii

S0033-0620(16)30051-2

journal_volume

59

pub_type

杂志文章,评审
  • Biology of ischemic cerebral cell death.

    abstract::With the approval of alteplase (tPA) therapy for stroke, it is likely that combination therapy with tPA to restore blood flow, and agents like glutamate receptor antagonists to halt or reverse the cascade of neuronal damage, will dominate the future of stroke care. The authors describe events and potential targets of ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(99)70002-2

    authors: Small DL,Morley P,Buchan AM

    更新日期:1999-11-01 00:00:00

  • Reducing infarct size in the setting of acute myocardial infarction.

    abstract::Acute myocardial infarction is caused by coronary occlusion, and the mainstay of treatment has become reperfusion by either coronary angioplasty with possible stenting or surgical bypass grafting. Unfortunately, reperfusion can seldom be done soon enough to prevent infarction. Thus, the search for effective cardioprot...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2006.02.005

    authors: Downey JM,Cohen MV

    更新日期:2006-03-01 00:00:00

  • New Concepts in Hypertension Management: A Population-Based Perspective.

    abstract::Hypertension (HTN) is the most common chronic disease in the U.S., and the standard model of office-based care delivery has yielded suboptimal outcomes, with approximately 50% of affected patients not achieving blood pressure (BP) control. Poor population-level BP control has been primarily attributed to therapeutic i...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2016.09.005

    authors: Milani RV,Lavie CJ,Wilt JK,Bober RM,Ventura HO

    更新日期:2016-01-01 00:00:00

  • Comparative effects of lipid-lowering therapies.

    abstract::The pharmacologic regulation of lipid metabolism in patients with dyslipidemia is unequivocally associated with significant reductions in risk for cardiovascular morbidity and mortality. A number of therapeutic drug classes have been developed in an effort to ever more precisely and intensively modulate lipid metaboli...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2004.04.007

    authors: Davidson MH,Toth PP

    更新日期:2004-09-01 00:00:00

  • Pathophysiological basis of syncope and neurological conditions that mimic syncope.

    abstract::The definition of syncope has clinical and pathophysiological parts. The clinical part is that syncope is a form of transient loss of consciousness (TLOC), while the pathophysiological element is that syncope differs from other forms of TLOC by virtue of the basis of true syncope - specifically cerebral hypoperfusion....

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2012.10.016

    authors: van Dijk JG,Wieling W

    更新日期:2013-01-01 00:00:00

  • The Current Global State of Key Lifestyle Characteristics: Health and Economic Implications.

    abstract::The chronic disease crisis we currently face must be addressed in rapid fashion. Cardiovascular (CV) and pulmonary diseases, diabetes as well as several forms of cancer are leading causes of morbidity and mortality globally. Collectively, these conditions have a significant impact on the quality of life of individuals...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2017.02.002

    authors: Arena R,McNeil A,Sagner M,Hills AP

    更新日期:2017-01-01 00:00:00

  • Tachycardia in hypertension: a saga of progress despite prejudice, confusion, and inertia.

    abstract::Tachycardia is a strong predictor of both hypertension and excessive cardiovascular risk. This association is robust and prevails after multivariate adjustments for other cardiovascular risk factors. Despite the strong evidence, various guidelines do not list tachycardia as a risk factor because of unwarranted assumpt...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2009.06.002

    authors: Julius S

    更新日期:2009-07-01 00:00:00

  • Impact of obesity and weight loss on cardiac performance and morphology in adults.

    abstract::Obesity, particularly severe obesity is capable of producing hemodynamic alterations that predispose to changes in cardiac morphology and ventricular function. These include increased cardiac output, left ventricular hypertrophy and diastolic and systolic dysfunction of both ventricles. Facilitated by co-morbidities s...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2013.09.003

    authors: Alpert MA,Omran J,Mehra A,Ardhanari S

    更新日期:2014-01-01 00:00:00

  • Risk stratification after acute myocardial infarction in the reperfusion era.

    abstract::Historically, risk stratification for survivors of acute myocardial infarction (AMI) has centered on 3 principles: assessment of left ventricular function, detection of residual myocardial ischemia, and estimation of the risk for sudden cardiac death. Although these factors still have important prognostic implications...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1053/pcad.2000.0420273

    authors: Michaels AD,Goldschlager N

    更新日期:2000-01-01 00:00:00

  • Role of antiarrhythmic agents after myocardial infarction with special reference to the EMIAT and CAMIAT trials of amiodarone. European Myocardial Infarct Amiodarone Trial. Canadian Amiodarone Myocardial Infarction Trial.

    abstract::The role of antiarrhythmic agents in the post-MI patients has been investigated for several years. Recently, clinical trials have assessed the effects of amiodarone in the post-MI population. The Basel Antiarrhythmic Study of Infarct Survival (BASIS) trial showed a reduction in total mortality, sudden death, and life-...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(98)80023-6

    authors: Jafri SM,Borzak S,Goldberger J,Gheorghiade M

    更新日期:1998-07-01 00:00:00

  • Clinical laboratory testing: what is the role of tilt-table testing, active standing test, carotid massage, electrophysiological testing and ATP test in the syncope evaluation?

    abstract::The first step in the diagnostic evaluation of patients with suspected syncope begins with an "initial evaluation" consisting of careful history taking, physical examination including orthostatic blood pressure measurement and electrocardiogram. However, even in expert centers the diagnostic yield of this "initial eva...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2012.11.002

    authors: Blanc JJ

    更新日期:2013-01-01 00:00:00

  • Natural history of thoracic aortic aneurysms: size matters, plus moving beyond size.

    abstract::Thoracic aortic aneurysms (TAAs) are a prevalent and deadly disease that, without diagnosis and treatment, eventuates in life-threatening aortic dissection or rupture. While TAAs normally grow in an indolent manner, once a certain size (a "hinge point") is reached, the risk of dissection, rupture, and death increases ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2013.05.007

    authors: Chau KH,Elefteriades JA

    更新日期:2013-07-01 00:00:00

  • In Defense of Sugar: A Critique of Diet-Centrism.

    abstract::Sugars are foundational to biological life and played essential roles in human evolution and dietary patterns for most of recorded history. The simple sugar glucose is so central to human health that it is one of the World Health Organization's Essential Medicines. Given these facts, it defies both logic and a large b...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.04.007

    authors: Archer E

    更新日期:2018-01-01 00:00:00

  • Obesity and Kidney Disease.

    abstract::Obesity is a systemic disease of the white adipose tissue, which has evolved into a global epidemic. It is associated with a plethora of adipocyte hormonal (adipokine) imbalances, dysregulation of the energy-balance system, imbalances in metabolic homeostasis, a pro-inflammatory state and multiple target organ damages...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.07.005

    authors: Lakkis JI,Weir MR

    更新日期:2018-01-01 00:00:00

  • Advanced Imaging Techniques for Mitral Regurgitation.

    abstract::Mitral regurgitation (MR) is one of the most commonly encountered valvular lesions in clinical practice. MR can be either primary (degenerative) or secondary (functional) depending on the etiology of MR and the pathology of the mitral valve (MV). Echocardiography is the primary diagnostic tool for MR and is key in det...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.10.001

    authors: Quien MM,Vainrib AF,Freedberg RS,Bamira DG,Benenstein RJ,Williams MR,Saric M

    更新日期:2018-01-01 00:00:00

  • Electrophysiological basis of QT dispersion measurements.

    abstract::Dispersion of ventricular repolarization is a now widely used term describing nonhomogeneous recovery of excitability or heterogeneity of ventricular repolarization. It is usually expressed as the difference or the range of various repolarization measurements obtained from a heart. Experimentally, an increased dispers...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1053/pcad.2000.0420311

    authors: Franz MR,Zabel M

    更新日期:2000-03-01 00:00:00

  • Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status.

    abstract::Several randomized trials and meta-analyses have shown that primary angioplasty is superior to thrombolysis in the treatment of ST-segment elevation myocardial infarction (MI) in terms of death, reinfarction, and stroke. However, primary angioplasty should be regarded as the preferred strategy as long as it can not be...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2007.11.004

    authors: De Luca G,Suryapranata H,Marino P

    更新日期:2008-03-01 00:00:00

  • CT Assessment of Myocardial Perfusion and Fractional Flow Reserve.

    abstract::Coronary computed tomography angiography (CTA) offers a non-invasive method to detect coronary plaque and stenosis. However, to date, CTA has been most useful as a method of ruling out coronary artery disease (CAD) among patients with low to intermediate pretest probability of significant CAD. The reduced specificity ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2015.03.003

    authors: Hulten E,Ahmadi A,Blankstein R

    更新日期:2015-05-01 00:00:00

  • Management of trastuzumab-related cardiac dysfunction.

    abstract::Trastuzumab is the standard of care for the treatment of patients with ERB2-positive breast cancer. In a minority of patients, trastuzumab is associated with an increased incidence of cardiac dysfunction that ranges from asymptomatic decreases in left ventricular ejection fraction to symptomatic heart failure. In tria...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2010.07.001

    authors: Carver JR

    更新日期:2010-09-01 00:00:00

  • Adverse reactions to quinidine in hospitalized patients: findings based on data from the Boston Collaborative Drug Surveillance Program.

    abstract::This study systematically analyzed the incidence and variety of adverse reactions to quinidine sulfate in 652 consecutively monitored hospitalized patients. Fourteen percent of the patients sustained adverse reactions of sufficient severity to warrant discontinuation of the drug. These reactions include GI intolerance...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/0033-0620(77)90004-4

    authors: Cohen IS,Jick H,Cohen SI

    更新日期:1977-09-01 00:00:00

  • Multimodality imaging in bicuspid aortic valve.

    abstract::Bicuspid aortic valve (BAV) patients are at increased risk of valve dysfunction and ascending aorta aneurysm. Imaging techniques are essential to establish diagnosis, identify complications and indicate surgical treatment. Transthoracic echocardiography (TTE) is the imaging technique of choice to diagnose BAV, valve m...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2020.06.003

    authors: Galian-Gay L,Rodríguez-Palomares J,Guala A,Michelena HI,Evangelista A

    更新日期:2020-01-01 00:00:00

  • Interventional echocardiography.

    abstract::Echocardiography guidance for interventions in the catheterization laboratory allows for reduction in radiation exposure from fluoroscopy as well as superior anatomic definition and visualization. The additional information provided over fluoroscopy has translated into an increasing use during interventional procedure...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2014.05.009

    authors: Pislaru SV,Michelena HI,Mankad SV

    更新日期:2014-07-01 00:00:00

  • The current global state of movement and physical activity - the health and economic costs of the inactive phenotype.

    abstract::Physical inactivity is one of the major contributing factors to the global pandemic of non-communicable diseases. Unfortunately, low levels of habitual movement and physical activity (PA) are seen in an increasing proportion of populations across low- and middle-income countries and high-income countries alike. This n...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2020.10.006

    authors: Jayasinghe S,Byrne NM,Patterson KAE,Ahuja KDK,Hills AP

    更新日期:2020-10-30 00:00:00

  • Economic impact of mechanical cardiac assistance.

    abstract::In contrast to heart transplantation, little effort has been made to estimate the economic implications of mechanical cardiac assistance from either a procedure- or a program-level perspective. With annual direct and indirect expenditures for the treatment of coronary artery disease and congestive heart failure now ex...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1053/pcad.2000.7201

    authors: Evans RW

    更新日期:2000-07-01 00:00:00

  • How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors.

    abstract::There is a strong evidence that more marked lowering of low-density lipoprotein cholesterol (LDL-C) leads to progressively lower risk of cardiovascular disease (CVD) events. The evidence on validity of this hypothesis comes from epidemiological, genetic and clinical studies. The hypothesis "the lower the better" has b...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2020.12.008

    authors: Cybulska B,Kłosiewicz-Latoszek L,Penson PE,Nabavi SM,Lavie CJ,Banach M,International Lipid Expert Panel (ILEP).

    更新日期:2020-12-28 00:00:00

  • Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.

    abstract::Dual antiplatelet therapy (DAPT) has been the cornerstone of antithrombotic management for patients undergoing percutaneous coronary intervention (PCI). However, approximately 10% of these patients have concomitant atrial fibrillation (AF) and require chronic oral anticoagulant (OAC) in addition to DAPT. This traditio...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.01.008

    authors: Kerneis M,Talib U,Nafee T,Daaboul Y,Pahlavani S,Pitliya A,Furqan MM,Datta S,Kazmi HA,Younes A,Gibson CM

    更新日期:2018-01-01 00:00:00

  • Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond.

    abstract::Renal injury distal to an atherosclerotic renovascular obstruction reflects multiple intrinsic factors producing parenchymal tissue injury. Atherosclerotic disease pathways superimposed on renal arterial obstruction may aggravate damage to the kidney and other target organs, and some of the factors activated by renal ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2009.09.002

    authors: Lerman LO,Textor SC,Grande JP

    更新日期:2009-11-01 00:00:00

  • Epidemiology of Pulmonary Hypertension in Left Heart Disease.

    abstract::Pulmonary hypertension (PH) in the setting of left side heart disease is associated with adverse outcomes. The exact prevalence of PH in the different pathologies that affect the left ventricle, however, is difficult to access with the current literature. The lack of a standard definition of PH in older studies, the d...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2016.07.001

    authors: Guha A,Amione-Guerra J,Park MH

    更新日期:2016-07-01 00:00:00

  • Stem cells and their potential in cell-based cardiac therapies.

    abstract::Stem cells are potential agents for the treatment of myocardial infarcts among other heart diseases. Over the past decade, the scientific community has extensively used a wide variety of cells and examined their capacity to both regenerate the infarcted myocardium and improve functionally the diseased hearts. Some of ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2007.02.006

    authors: Christoforou N,Gearhart JD

    更新日期:2007-05-01 00:00:00

  • Special considerations in the therapy of diabetic hypertension.

    abstract::Patients with diabetes mellitus have an increased prevalence of hypertension and associated cardiovascular disease (CVD), including coronary and cerebrovascular disease. The risk of an individual of developing CVD is much greater when both diseases coexist and is further magnified by their frequent association with dy...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(99)70022-8

    authors: Guzmán CB,Sowers JR

    更新日期:1999-05-01 00:00:00